Avandia Side Effects Lawsuit Filed in Louisiana Federal Court
GlaxoSmithKline, maker of the controversial diabetes medication Avandia, is facing a new lawsuit filed in federal court from a Louisiana resident who claims he suffered a stroke after taking the drug.
According to court documents, John Anderson and his wife Connie filed the lawsuit in a New Orleans court on December 21st. The couple claims that GlaxoSmithKline deliberately concealed data about the potential risks associated with the drug and that failed to provide physicians and patients with accurate information about Avandia’s safety and effectiveness.
The plaintiffs also claim that the drug is linked to serious side effects, including heart damage, excessive fluid retention, fluid-overload disease, liver damage, liver failure and cardiac arrest and in some cases, death. Mr. Anderson claims that he specifically suffered eye hemorrhages and on August 20, 2011, a stroke.
The couple is seeking an unspecified amount of damages for physical and mental pain and suffering, medical expenses, loss of quality of life, lost wages, lost earning capacity, loss of companionship, interest and court costs. GlaxoSmithKline has not yet released an official statement regarding the lawsuit.
Avandia was approved by the U.S. Food and Drug Administration in 1999 to treat Type 2 diabetes in adult patients. That same year, the FDA also approved Actos, another diabetes drug, which has since been linked to an increased risk of bladder cancer.
This will not be the first time the company has faced legal trouble with regards to Avandia. In November 2011, the company reached a $3 billion settlement agreement with the U.S. government after an extensive investigation proved that Avandia and other drugs were illegally marketed.
Prior to negotiating a settlement with the government, it was speculated that GlaxoSmithKline had also agreed to pay $700 million to settle approximately 10,000 lawsuits from Avandia users who claimed they were injured after taking the drug. After the November settlement agreement, a federal judge set a 75-day deadline requiring the company to settle 85 percent of the remaining lawsuits or face going to trial.
It remains unclear exactly how many cases are still pending but with new cases being filed, it will likely take some for GlaxoSmithKline to resolve the legal issues associated with the drug. The FDA has required updated warning labels for the drug but as of yet, there are no plans for an Avandia recall.
Diabetes patients who’ve suffered serious complications after taking Avandia need to understand their rights and how to protect them. If you or a loved on experienced a heart attack, stroke or adverse health condition after using the diabetes drug, you need to contact the law firm of Nadrich & Cohen LLP right away.
We are currently investigating claims from Avandia users in all 50 states and we are eager to discuss your case. Your initial case evaluation is free and there is never a fee unless we recover a judgment on your behalf. Contact us today to get the legal representation you need and the compensation you deserve for your Avandia injury case.